June 6-8, 2016
Rio de Janeiro, Brazil
DNDi Latin America are organizing a series of events with conferences, discussions and meetings, the final event, the Partners`Meeting takes place on June 8th 2016 in Rio de Janeiro, Brazil. Participants, from the field of research & development on neglected diseases, including international scientists, product developers, policy-makers, and civil society organizations, are invited to participate in the events in order to do the best science for the most neglected.
June 6-8, 2016
April 25, 2016
The Swiss Malaria Group are marking the occasion of World Malaria Day in Bern. The group will inform the public about the commitment of the Swiss Malaria Group Association in the fight against malaria and about the devastation still caused by malaria in the world.
April 19-21, 2016
Carolina Batista, Regional Medical Manager, and Andrea Marchiol, Coordinator for the Chagas Operational Projects, will be presenting on access to treatment for Chagas disease.
March 16-17, 2016
London, United Kingdom
The upcoming Superbugs and Superdrugs conference will address the core challenges in the industry from: Investment, R&D to hospital hygiene, and consumer engagement and review current strategies. Jean-Pierre Paccaud, Business Development Director from DNDi, will discuss global product development partnerships as a means of fostering new antibiotic treatments and discuss their responsible use.
March 2-5, 2016
Suman Rijal, Director of DNDi Regional Office India, will be co-chairing a symposium on visceral leishmaniasis in South Asia, and Vishal Goyal, Clinical Manager, will be presenting.
6th International Symposium on Current Trends in Drug Discovery and Research
February 25-28, 2016
Robert Don, Graeme Bilbe, and Suman Rijal and will be presenting in a session on infectious diseases.
February 9, 2016
DNDi is chairing and presenting at a symposium on innovation for access to treatment for neglected diseases at the first ASTMH in Kenya.
February 5, 2016
The Hague, Netherlands
During its Presidency of the Council of the European Union, the Government of the Netherlands has committed to improving affordable access to safe and effective medicines. But how can it create real and lasting change? Join public health experts and government representatives to debate these issues. The event is being coordinated by DNDi and other partners.
January 24-28, 2016
DNDi, participated in this conference on drug discovery for parasitic diseases.
January 8, 2016
Glasgow, Scotland, United Kingdom
DNDi‘s Head of Visceral Leishmaniasis, Jorge Alvar, presented on leishmaniasis in honour of the 150th anniversary of Prof. Sir William Boog Leishman.
December 02, 2015
European Parliament, Brussels, Belgium
Dr Bernard Pécoul, Executive Director of DNDi, spoke in a Q&A Session entitled: “What are some of the possible cures for our ailing and expensive pharmaceutical model?”
[October 25-29, 2015]
Philadelphia, United States
DNDi participated in the 64th Annual Meeting of ASTMH.
[October 26-28, 2015]
European Cooperation in Science and Technology
Jean-Robert Ioset, Discovery Manager, DNDi presented on drug discovery against kinetoplastid diseases.
[October 15, 2015]
New Delhi, India
DNDi India hosted a Stakeholders’ Event to launch DNDi `s new Business Plan, 2015-2023.
[October 11-13, 2015]
DNDi`s Business Development Director, Jean-Pierre Paccaud co-chaired a workshop entitled: “Global Health Research for Development”.
[October 09-11, 2015]
Dr Suman Rijal, Director of DNDi Regional Office India, presented on the challenges for diagnosis in visceral leishmaniasis
[October 2, 2015]
Rachel Cohen, Regional Executive Director of DNDi North America spoke in a session entitled: “Free Trade at What Cost? R&D for Neglected Diseases”.
[September 14-18, 2015]
DNDi made several presentations on sleeping sickness.
[September 07, 2015]
On the occasion of the 9th European Congress on Tropical Medicine and International Health (ECTMIH) in Basel, Switzerland, DNDi hosted a Stakeholders’ Event to launch DNDi `s new Business Plan, 2015-2023.